Skip to main content
Clinical Trials/NCT05079373
NCT05079373
Unknown
Not Applicable

Study of Neurological Damage From Coronavirus Disease (COVID-19): Extraction of Quantitative Imaging Biomarkers for the Characterization of Pathological Profiles

University Hospital, Strasbourg, France1 site in 1 country250 target enrollmentApril 1, 2021
ConditionsCOVID-19

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
COVID-19
Sponsor
University Hospital, Strasbourg, France
Enrollment
250
Locations
1
Primary Endpoint
Retrospective study of the neurological damage in patients with Covid-19
Last Updated
4 years ago

Overview

Brief Summary

The objective of this study is to support the exploration of the NEURO-COVID-19 database and in particular to carry out the post-treatments necessary to derive quantitative information on the characterization of the lesion load, in particular with regard to of the vascular tree

Registry
clinicaltrials.gov
Start Date
April 1, 2021
End Date
October 31, 2022
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University Hospital, Strasbourg, France
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Retrospective study of the neurological damage in patients with Covid-19

Time Frame: Files analysed retrospectively from January 01, 2020 to October 31, 2021 will be examined]

Study Sites (1)

Loading locations...

Similar Trials